NASDAQ:DHCNL • US25525P3055
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL).
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.41B 9.87% | 1.495B 6.04% | 1.538B 2.84% | 1.607B 4.50% | 1.696B 5.54% | |
| EBITDA YoY % growth | 210.026M 41.85% | 232.367M 10.64% | 233.011M 0.28% | 290.61M 24.72% | 312.4M 7.50% | |
| EBIT YoY % growth | -74.057M 18.81% | -52.59M 28.99% | -28.912M 45.02% | 78.024M 369.87% | N/A | |
| Operating Margin | -5.25% | -3.52% | -1.88% | 4.86% | N/A | |
| EPS YoY % growth | -0.92 36.06% | -1.05 -14.04% | -1.10 -4.76% | -0.56 49.50% | -0.51 8.18% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 -403.00% | -0.14 62.79% | -0.16 76.24% | -0.13 -45.89% | -0.13 13.33% | -0.13 7.14% | -0.15 6.25% | -0.12 7.69% |
| Revenue Q2Q % growth | 381.45M -1.40% | 393.81M 2.90% | 407.39M 4.81% | 414.63M 9.24% | 418.75M 9.78% | 420.28M 6.72% | 424.43M 4.18% | 431.68M 4.11% |
| EBITDA Q2Q % growth | 71.477M 12.49% | 72.051M -43.39% | 67.795M -63.38% | 75.167M -71.08% | 80.8M 13.04% | 83.325M 15.65% | 74.942M 10.54% | 80.598M 7.23% |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
7 analysts have analysed DHCNL and the average price target is 17.2 USD. This implies a price decrease of -6.04% is expected in the next year compared to the current price of 18.31.
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is -0.15 USD and the consensus revenue estimate is 381.45M USD.
The number of analysts covering DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is 7.